ActivePhase 3ACTRN12611000247976

Does lactoferrin improve survival free from morbidity in very low birth weight infants? Lactoferrin Infant Feeding Trial: a randomised controlled trial

Sponsor

University of Sydney

Enrollment

1,500 participants

Start Date

Jun 18, 2014

Study Type

Interventional

Conditions

Premature babies

Summary

A two arm randomised controlled trial in more than 1500 preterm babies less than 1500 grams to compare standard feeding regimens versus adding BLF to feeds on the incidence of death and major disability in VLBW infants.

Eligibility

Sex: Both males and femalesMax Age: 7 Dayss

Plain Language Summary

Simplified for easier understanding

This study tests whether adding lactoferrin (a protein naturally found in breast milk) to the diet of very small premature babies can help them survive without serious health complications. It is for newborns weighing less than 1,500 grams (about 3.3 pounds) who are no more than 7 days old.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Bovine Lactoferrin (BLF): Dosage - 200 mg/kg/day added to breast milk or formula, once daily. Study intervention is administered until 34 weeks corrected gestation or for 2 weeks, whichever is longe

Bovine Lactoferrin (BLF): Dosage - 200 mg/kg/day added to breast milk or formula, once daily. Study intervention is administered until 34 weeks corrected gestation or for 2 weeks, whichever is longer, or until discharge home, if earlier.

Locations(1)

Christchurch; Wellington, New Zealand

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12611000247976

Related Trials

A randomised trial to see if closing the arterial duct improves outcome in very premature babies

ACTRN126070005324042 locations